v3.26.1
Note 6 - China Joint Venture
6 Months Ended
Jun. 30, 2026
Notes to Financial Statements  
Noncontrolling Interest Disclosure [Text Block]

NOTE 6.     CHINA JOINT VENTURE

 

In 2019, the Company executed a joint venture agreement with its Chinese supplier (the “China JV”) whereby the Company has a 51% ownership interest. The agreement required the Company to make capital contributions of approximately $357,000 into the newly formed entity, which were made in prior years. In June 2023, the Company executed an amendment to the joint venture agreement to increase the amount of its registered capital. The amendment requires the Company to make additional capital contributions to the China JV of $408,000, of which $214,000 has been made as of June 30, 2026. During May 2025, the China JV executed a distribution agreement with a Chinese distributor and commenced operations during the second quarter of 2025. 

 

During 2024, the Company determined that the contributions made to the China JV to date are not sufficient for the China JV to fund expected losses without additional subordinated financial support. Accordingly, the Company has determined that the China JV is a variable interest entity (“VIE”). The Company has determined that because it has the sole right to direct the activities of the China JV that most significantly impact its economic performance, and as the majority owner, has the obligation to absorb losses of the VIE and the right to receive benefits from the VIE that are significant to the China JV, that the Company is the primary beneficiary of the VIE. Accordingly, the China JV has been consolidated in these consolidated financial statements.

 

The China JV is organized as a limited liability company under the laws of the People’s Republic of China, accordingly the Company’s exposure to losses in the China JV is limited to the Company’s registered capital in the Company, which is equal to the sum of the required capital contributions above. As the China JV is not currently sufficiently capitalized, the assets of the China JV are not available to settle obligations of the Company.

 

The following table summarizes the assets and liabilities of the China JV, a consolidated variable interest entity, included in the Company’s consolidated balance sheets at June 30, 2026 and December 31, 2025, respectively:

 

  

June 30,

  

December 31,

 
  

2026

  

2025

 

(In thousands)

        

Cash and cash equivalents

 $175  $383 

Trade accounts receivable

  726   213 

Inventories

  26   31 

Prepaid expenses and other current assets

  8   12 

Property and equipment, net

  213   225 
         

Accounts payable

     186 

Accrued expenses and other current liabilities

  93   63 

 

Changes in the Company’s ownership investment in the China JV were as follows:

 

  

Three Months Ended

  

Six Months Ended

 
  

June 30,

  

June 30,

 

(In thousands)

 

2026

  

2025

  

2026

  

2025

 

Beginning interest in China JV

 $266  $138  $303  $130 

Contributions

     30      61 

Net loss attributable to Apyx

  178   42   141   19 

Ending interest in China JV

 $444  $210  $444  $210